Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Clostridium Difficile Infection
Interventions: Drug: MIYA-BM Fine Granules (CBM588); Drug: Placebo Fine Granules (without CBM588)
Sponsor: Osel, Inc.
Recruiting - verified February 2010
Condition: Diarrhea
Interventions: Biological: Heat-Labile Enterotoxin of E. coli (LT); Biological: Placebo
Sponsor: Intercell USA, Inc.
Recruiting - verified February 2010
Condition: Exercise Induced Asthma
Interventions: Drug: Budesonide/Formoterol; Drug: Budesonide
Sponsors: Children's Hospital Boston; Brigham and Women's Hospital
Recruiting - verified February 2010
Conditions: Inflammation; Colon, Irritable; Colonic Diseases, Functional; Irritable Bowel Syndrome
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Colon, Irritable
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Recurrent Grade IV Malignant Glioma
Intervention: Drug: Panitumumab in Combination with Irinotecan
Sponsors: Duke University; Amgen
Recruiting - verified February 2010
Condition: Breast Cancer
Interventions: Other: Side-effect questionnaires; Other: research blood samples
Sponsors: University of Chicago; Translational Breast Cancer Reserach Consortium; National Institutes of Health (NIH)
Recruiting - verified February 2010
Condition: Irritable Bowel Syndrome
Intervention: Biological: Probiotic
Sponsors: Baylor College of Medicine; National Institute of Nursing Research (NINR); University of Washington
Recruiting - verified March 2010
Condition: Carcinoid Syndrome
Interventions: Drug: lanreotide; Drug: placebo
Sponsors: Tercica; Ipsen
Recruiting - verified March 2010
Condition: Neoplasms
Intervention: Drug: BIBW 2992
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Escherichia Coli Infections
Interventions: Drug: Ciprofloxacin 500 mg; Biological: Peru-15-pCTB; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Diarrhea Predominant Irritable Bowel Syndrome
Intervention: Other: Very low carbohydrate diet
Sponsor: The University of North Carolina, Chapel Hill
Not yet recruiting - verified June 2009
Condition: Prostatic Hyperplasia
Interventions: Drug: Polyphenon E, 200 mg EGCG bid; Drug: placebo
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Recruiting - verified February 2010
Conditions: Abdominal Pain; Irritable Bowel Syndrome
Intervention: Behavioral: Elimination Diet
Sponsors: Baylor College of Medicine; National Institute of Nursing Research (NINR)
Recruiting - verified March 2010
Condition: Norovirus
Interventions: Biological: Norwalk Virus; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
All Categories ... by Medical Condition » ... Diarrhea » ... United States 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
